Literature DB >> 17983900

Penile rehabilitation following radical prostatectomy: role of early intervention and chronic therapy.

Craig D Zippe1, Geetu Pahlajani.   

Abstract

The increase in the number of prostate cancer survivors and their relatively young age has prompted many urologists to concentrate on early penile rehabilitation to improve potency rates following radical prostatectomy. Positive results from various procedures range from 14% to 81% following bilateral nerve-sparing laparoscopic radical prostatectomy, to 43% to 97% following robotic-assisted laparoscopic prostatectomy. An early program with an erectaid improves erectile physiology and performance and logistically, the combination of a 5-phosphodiesterase inhibitor and a vacuum constriction device may prove to be the most user-friendly, cost-effective, and patient-compliant. Other issues that affect patient compliance, such as loss of interest and fear of undertaking sexual activity, will only be revealed through long-term patient follow-up and care.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17983900     DOI: 10.1016/j.ucl.2007.08.012

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  14 in total

1.  Penile rehabilitation following treatment for prostate cancer: an analysis of the current state of the art.

Authors:  Tariq Al Shaiji; Trustin Domes; Gerald Brock
Journal:  Can Urol Assoc J       Date:  2009-02       Impact factor: 1.862

2.  Should penile rehabilitation become the norm following radical prostatectomy?

Authors:  Tariq Al Shaiji; Mb Chb; Gerald Brock
Journal:  Can Urol Assoc J       Date:  2009-02       Impact factor: 1.862

3.  Vacuum erection devices to treat erectile dysfunction and early penile rehabilitation following radical prostatectomy.

Authors:  Craig D Zippe; Geetu Pahlajani
Journal:  Curr Urol Rep       Date:  2008-11       Impact factor: 3.092

Review 4.  [Corpus cavernosum rehabilitation after radical urooncological procedures].

Authors:  D-H Zermann
Journal:  Urologe A       Date:  2008-06       Impact factor: 0.639

5.  Outcome of preemptive penile rehabilitation before bilateral cavernosal nerve injury in rats.

Authors:  Hasan Hüseyin Tavukçu; Cem Akbal; Ilker Tinay; Ferruh Simşek; Levent Türkeri
Journal:  World J Urol       Date:  2009-12-12       Impact factor: 4.226

Review 6.  Systematic review and meta-analysis of the use of phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction following bilateral nerve-sparing radical prostatectomy.

Authors:  Xiao Wang; Xinghuan Wang; Tao Liu; Qianwen He; Yipeng Wang; Xinhua Zhang
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

7.  30-day adverse event rates following penile prosthesis surgery: an American College of Surgeons National Surgical Quality Improvement Program based evaluation.

Authors:  Isaac Palma-Zamora; Akshay Sood; Ali A Dabaja
Journal:  Transl Androl Urol       Date:  2017-11

8.  Synergistic effect of mesenchymal stem cells infected with recombinant adenovirus expressing human BDNF on erectile function in a rat model of cavernous nerve injury.

Authors:  Su Jin Kim; Sae Woong Choi; Kyung Jae Hur; Sang Hoon Park; Young Chul Sung; Y-Shin Ha; Hyuk Jin Cho; Sung-Hoo Hong; Ji Youl Lee; Tae-Kon Hwang; Sae Woong Kim
Journal:  Korean J Urol       Date:  2012-10-19

9.  The Efficacy and Safety of Tadalafil 5 mg Once Daily in the Treatment of Erectile Dysfunction After Robot-Assisted Laparoscopic Radical Prostatectomy: 1-Year Follow-up.

Authors:  Young Eun Seo; Soo Dong Kim; Tae Hyo Kim; Gyung Tak Sung
Journal:  Korean J Urol       Date:  2014-02-14

10.  Minimally invasive infrapubic inflatable penile prosthesis implant for erectile dysfunction: evaluation of efficacy, satisfaction profile and complications.

Authors:  G Antonini; G M Busetto; E De Berardinis; R Giovannone; P Vicini; F Del Giudice; S L Conti; V Gentile; P E Perito
Journal:  Int J Impot Res       Date:  2015-12-10       Impact factor: 2.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.